Search Results - "Sen, Shuvayu S."

Refine Results
  1. 1

    Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery by Boon, Martijn, Martini, Chris, Yang, H Keri, Sen, Shuvayu S, Bevers, Rob, Warlé, Michiel, Aarts, Leon, Niesters, Marieke, Dahan, Albert

    Published in PloS one (23-05-2018)
    “…Recent data shows that a neuromuscular block (NMB) induced by administration of high doses of rocuronium improves surgical conditions in certain procedures…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Real‐World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the U.S by Yang, Xiaoqin, Laliberté, François, Germain, Guillaume, Raut, Monika, Duh, Mei Sheng, Sen, Shuvayu S., Lejeune, Dominique, Desai, Kaushal, Armand, Philippe

    Published in The oncologist (Dayton, Ohio) (01-05-2021)
    “…Background Diffuse large B‐cell lymphoma (DLBCL) represents the most common subtype of non‐Hodgkin lymphoma in the U.S., but current real‐world data are…”
    Get full text
    Journal Article
  5. 5

    Association between gastrointestinal events and compliance with osteoporosis therapy by Siris, Ethel S, Fan, Chun-Po Steve, Yang, Xiaoqin, Sajjan, Shiva, Sen, Shuvayu S, Modi, Ankita

    Published in Bone Reports (01-06-2016)
    “…The aim of this study was to estimate the rate of gastrointestinal (GI) events, and association between GI events and compliance with osteoporosis therapy…”
    Get full text
    Journal Article
  6. 6

    An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: physician and patient attitudes and beliefs by Chan, Siew Pheng, Scott, Boyd B, Sen, Shuvayu S

    Published in BMC musculoskeletal disorders (26-10-2010)
    “…Osteoporosis treatment guidelines recommend calcium and vitamin D supplementation for both prevention as well as treatment, however, compliance with these…”
    Get full text
    Journal Article
  7. 7

    Estimation of resource utilization associated with osteoporotic hip fracture and level of post-acute care in China by Dai, Kerong, Zhang, Qiaoyi, Fan, Tao, Sen, Shuvayu S.

    Published in Current medical research and opinion (01-12-2007)
    “…ABSTRACT Objective: Research suggests that the incidence and cost of treating osteoporotic hip fracture (OHF) in China is rising. The purpose of this study was…”
    Get full text
    Journal Article
  8. 8

    Epidemiology of falls and osteoporotic fractures: a systematic review by Morrison, Alan, Fan, Tao, Sen, Shuvayu S, Weisenfluh, Lauren

    Published in ClinicoEconomics and outcomes research (01-01-2013)
    “…Fractures in elderly populations result from the combination of falls and osteoporosis. We report a systematic review of studies indexed in PubMed reporting…”
    Get full text
    Journal Article
  9. 9

    An Evaluation of patients' preferences for osteoporosis medications and their attributes: The PREFER-international study by Duarte, Jesús Walliser, MD, Bolge, Susan C., PhD, Sen, Shuvayu S., PhD

    Published in Clinical therapeutics (01-03-2007)
    “…Abstract Background: Patients' preferences for medications may be important in determining their compliance with therapy, particularly in the case of an…”
    Get full text
    Journal Article
  10. 10

    Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States by Yang, Xiaoqin, Laliberté, François, Germain, Guillaume, Raut, Monika, Duh, Mei Sheng, Sen, Shuvayu S, Lejeune, Dominique, Desai, Kaushal, Armand, Philippe

    Published in Journal of medical economics (01-01-2021)
    “…With the advent of ICD-10-CM codes for PMBCL on 10/01/2015, assessment of treatment patterns and healthcare burden among US patients is possible. This study…”
    Get more information
    Journal Article
  11. 11

    Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review by Copley-Merriman, Catherine, Yang, Xiaoqin, Juniper, Melissa, Amin, Suvina, Yoo, Hyun Kyoo, Sen, Shuvayu S

    “…Neurofibromatosis type 1 (NF1) is an incurable genetic condition that frequently includes the development of plexiform neurofibromas (PNs) in patients. A…”
    Get full text
    Journal Article
  12. 12

    Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA by Laliberté, François, Raut, Monika, Yang, Xiaoqin, Germain, Guillaume, Nahar, Akash, Desai, Kaushal D., MacKnight, Sean D., Sen, Shuvayu S., Duh, Mei Sheng

    Published in Targeted oncology (01-01-2021)
    “…Background Patients with classical Hodgkin lymphoma (cHL) relapsed or refractory (R/R) disease who relapse after or are ineligible for autologous stem cell…”
    Get full text
    Journal Article
  13. 13

    Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: A meta-analysis by Bergman, Gert J.D., Fan, Tao, McFetridge, Jeffrey T., Sen, Shuvayu S.

    Published in Current medical research and opinion (01-05-2010)
    “…Abstract Background: The efficacy of vitamin D3 in preventing fractures and falls has been explored in a number of clinical trials. However, recent evidence…”
    Get full text
    Journal Article
  14. 14

    How Do Physicians Weigh Benefits and Risks Associated with Treatments in Patients with Osteoarthritis in the United Kingdom? by ARDEN, Nigel K, HAUBER, A. Brett, MOHAMED, Ateesha F, JOHNSON, F. Reed, PELOSO, Paul M, WATSON, Douglas J, MAVROS, Panagiotis, GAMMAITONI, Arnold, SEN, Shuvayu S, TAYLOR, Stephanie D

    Published in Journal of rheumatology (01-05-2012)
    “…To quantify the relative importance that UK physicians attach to the benefits and risks of current drugs when making treatment decisions for patients with…”
    Get full text
    Journal Article
  15. 15

    Undertreatment with anti-osteoporotic drugs after hospitalization for fracture by PANNEMAN, Martien J. M, LIPS, Paul, SEN, Shuvayu S, HERINGS, Ron M. C

    Published in Osteoporosis international (01-02-2004)
    “…This study assessed the proportion of patients treated with anti-osteoporotic drugs during the 1-year period after hospitalization for a fracture, and the…”
    Get full text
    Journal Article
  16. 16

    Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study by Fan, Tao, Nocea, Gonzalo, Modi, Ankita, Stokes, Leah, Sen, Shuvayu S

    Published in Clinical interventions in aging (01-01-2013)
    “…Osteoporotic fractures are important causes of morbidity, mortality, and increased health care costs. However, the risk of osteoporotic fractures can be…”
    Get full text
    Journal Article
  17. 17

    Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database by Fan, Tao, Zhang, Qiaoyi, Sen, Shuvayu S

    Published in ClinicoEconomics and outcomes research (01-01-2013)
    “…Bisphosphonates are available in daily, weekly, and monthly dosing formulations to treat postmenopausal osteoporosis. Some researchers suggested that adherence…”
    Get full text
    Journal Article
  18. 18

    Gastrointestinal events and association with initiation of treatment for osteoporosis by Modi, Ankita, Siris, Ethel S, Tang, Jackson, Sajjan, Shiva, Sen, Shuvayu S

    Published in ClinicoEconomics and outcomes research (01-01-2015)
    “…Preexisting gastrointestinal (GI) events may deter the use of pharmacologic treatment in patients diagnosed with osteoporosis (OP). The objective of this study…”
    Get full text
    Journal Article
  19. 19

    Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands by Jansen, Jeroen P., Gaugris, Sabine, Bergman, Gert, Sen, Shuvayu S.

    Published in Current medical research and opinion (01-03-2008)
    “…ABSTRACT Objective: To evaluate the cost-effectiveness of a fixed dose combination of alendronate 70 mg and cholecalciferol 2800 IU (alendronate/vitamin D3;…”
    Get full text
    Journal Article
  20. 20

    Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden by Borgström, Fredrik, Johnell, Olof, Jönsson, Bengt, Zethraeus, Niklas, Sen, Shuvayu S

    Published in Bone (New York, N.Y.) (01-06-2004)
    “…Background: One third of all the hip fractures occur in men. The risk for mortality following hip fracture is higher for men compared to women. The Fracture…”
    Get full text
    Journal Article